Risk stratification is essential for balancing the risks of VTE and bleeding when considering thromboprophylaxis in pregnant and postpartum women.
Answers are grounded in this paper and cite their sources.
Requires careful risk-benefit assessment before thromboprophylaxis in pregnancy; leaves open validation of specific tools in prospective studies.
Pregnancy-associated venous thromboembolism (VTE) is a leading cause of maternal mortality, but is relatively uncommon. It is clear that the antepartum and postpartum periods have different magnitudes of risk and distinct risk factors for VTE and therefore must be considered separately. Absolute daily risks of VTE must be understood and explored when deciding to prescribe antepartum or postpartum thromboprophylaxis and must also be balanced against the downsides of prophylaxis. When the risks for VTE and bleeding are both low, other burdens of thromboprophylaxis must be weighed in and a decision made after an individualized patient values- and patient preferences-based discussion. Risk stratification is essential to ensure that the practicing clinician strikes the right balance.
No takes yet. Share an insight, caveat, or question.
Marc Rodger (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: